Post Issuance Proceedings In Japan (Presentation)

Finnegan attorney Chiaki Kobayashi explores the complex landscape of genus claiming in biotechnology and pharmaceutical patents, examining doctrinal developments and practical drafting approaches. The article, edited by partner John D. Livingstone, provides strategic guidance for navigating means-plus-function claiming methodologies in life sciences intellectual property.

Finnegan attorneys Naoki Yoshida and Chiaki Kobayashi examine emerging patterns in discretionary denial practices at the Patent Trial and Appeal Board under the Squires Administration, analyzing their impact on corporate intellectual property strategy and practice. This article, published in the Japan Intellectual Property Association's journal, explores how recent administrative changes are reshaping PTAB proceedings and what corporate practitioners need to know to adapt their IP management approaches.

Japanese police have arrested an alleged first uploader on Nyaa, the torrent index at the heart of anime piracy, marking a strategic shift from blocking sites to targeting source distributors. Using attribution tools developed under CODA's Cross-Border Enforcement Project, investigators identified and detained a Kanagawa resident suspected of seeding an NHK drama and numerous other works. This case signals a new enforcement approach focused on chokepoints in the distribution chain rather than endless domain

6月12日、日本国特許庁（JPO）のホストの下、第19回五庁長官会合が開催され、中国国家知識産権局の張志成副局長がオンラインで出席した。

商標行政事件の処理の質と効率を持続的に向上させ、知的財産権の法的な保障を強化するため、国家知的財...

The Japan Patent Office's 2026 Status Report reveals a significant 17% surge in patent applications driven by an unusual December filing spike, while registration rates and examination timelines remain stable.

A Japanese manufacturer of reduced coenzyme Q10 won a patent infringement case against two American competitors, only to watch its victory unravel when the defendants reformulated their products. Racing to a second trial with predictive chemical testing rather than waiting for complete shelf-life data, the patent owner learned a costly lesson about the intersection of litigation strategy and laboratory timelines.

組成物に関発明専利出願では、実験データがほぼ不可欠であり、その役割は明細書に主張された技術効果を裏付けることにあります。

商标共存制度作为解决商标权利冲突的一种机制，在商标确权案件中发挥着重要作用。

在知识经济时代，专利不仅是保护创新成果的法律工具，更是企业参与全球竞争、获取市场优势的核心战略资产。传统的专利审查周期通常长达数